It was reported that CXCL2 could enhance survival of primary chronic lymphocytic leukemia cells in vitro and differential expression of CXCL2 in colon cancer had impact on metastatic disease and survival [28], [29]. This evidence concerns the gene CXCL2 and B-cell chronic lymphocytic leukemia.